CV Sciences, Inc. (CVSI)

Market Cap	5.96M +4.0%
Revenue (ttm)	13.79M -12.2%
Net Income	-958.00K
EPS	-0.01
Shares Out	193.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	206,769
Average Volume	879,457
Open	0.0307
Previous Close	0.0300
Day's Range	0.0307 - 0.0320
52-Week Range	0.0230 - 0.1000
Beta	0.51
RSI	40.20
Earnings Date	Mar 26, 2026

About CV Sciences

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements, hemp-based cannabidiol (CBD), and plant based food products in North America. It offers its products under the PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in Jan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Employees: 44
• Stock Exchange: OTCMKTS
• Ticker Symbol: CVSI

Financial Performance

In 2025, CV Sciences's revenue was $13.79 million, a decrease of -12.20% compared to the previous year's $15.71 million. Losses were -$958,000, -59.98% less than in 2024.